Modified Vaccinia Ankara Vaccine (Chinese University of Hong Kong)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameModified Vaccinia Ankara Vaccine (Chinese University of Hong Kong)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionEpstein-Barr nuclear antigen 1 stimulants
TargetsEpstein-Barr nuclear antigen 1
Therapy Area/IndicationsNasopharyngeal NeoplasmsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChinese University Of Hong Kong (Cuhk)Cancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinese University Of Hong Kong (Cuhk)
Active IndicationsN/A
Inactive IndicationsNasopharyngeal NeoplasmsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A